Seems trials getting started this week meaning we can treat without emergency if severe patients are included in trial, plus we will see how drug helps before they become critical in the mild to moderate stage.

"We eagerly await the results of additional patients treated under the FDA’s emergency IND program, as well as the results of several randomized clinical trials about to start.”